Related Experiment Video
Updated: Jun 6, 2025

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
[Expert consensus on the diagnosis and treatment of pyruvate kinase deficiency]
Insights
Pyruvate kinase deficiency (PKD) is a rare genetic disorder affecting red blood cells. This consensus provides guidance on diagnosing and managing PKD, including its complications and treatment.
Area of Science:
- Genetics and Molecular Biology
- Hematology
- Metabolic Disorders
Context:
- Pyruvate kinase deficiency (PKD) is a rare autosomal recessive disorder.
- Mutations in the PKLR gene impair erythrocyte energy production.
- This leads to chronic hemolytic anemia and related complications.
Purpose:
- To provide a comprehensive consensus on PKD.
- To guide clinicians in diagnosis, treatment, and complication management.
- To improve medical services for patients with pyruvate kinase deficiency.
Summary:
- Focuses on the pathogenesis, clinical characteristics, diagnosis, and treatment of PKD.
- Highlights the need for individualized treatment approaches.
- Covers complications like iron overload and cardiopulmonary issues.
Impact:
- Aims to enhance the medical care provided to PKD patients.
- Offers a valuable resource for clinicians managing this rare condition.
- Contributes to better monitoring and prevention strategies for PKD complications.
Abstract:
Pyruvate kinase deficiency (PKD) is a rare autosomal recessive disorder caused by mutations in the PKLR gene, encoding erythrocyte pyruvate kinase, which affects erythrocyte energy production, and then in turn affects erythrocyte function and longevity. PKD is characterized by chronic hemolytic anemia, and other features include chronic hemolytic complications, such as iron overload, decreased bone mineral density, and cardiopulmonary complications. The treatment of PKD requires individualized approach based on the patient's condition, including red blood cell transfusions, pyruvate kinase activators, and treatment for complications. This consensus focuses on the pathogenesis, clinical characteristics, diagnosis and treatment of PKD, and aims to provide better medical service for clinicians, such as diagnosis, treatment, monitoring, and prevention of complications for PKD patients.
Related Concept Videos
Inborn Errors of Metabolism
Fates of Pyruvate
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...

